share

3-Isoquinolinecarboxamide, n-[[3-[4-(Diethylamino)-6-Quinazolinyl]Phenyl]Methyl]-n-Methyl- CAS NO 950568-48-6


Unit Price:

CAS No.:950568-48-6

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

3-Isoquinolinecarboxamide, n-[[3-[4-(Diethylamino)-6-Quinazolinyl]Phenyl]Methyl]-n-Methyl- is a high-purity, advanced pharmaceutical intermediate of significant interest in modern drug discovery. This compound matters for its role as a key building block in the synthesis of targeted therapeutic agents, particularly kinase inhibitors. Pharmaceutical R&D and fine chemical synthesis companies need this material for developing novel treatments in oncology and other therapeutic areas.

Application

  • Pharmaceutical Intermediate: Critical building block for the synthesis of novel kinase inhibitor candidates targeting specific disease pathways.
  • Oncology Research: Used in the development and optimization of small-molecule drugs for cancer therapy.
  • Biochemical Screening: Serves as a reference standard or a core scaffold in high-throughput screening libraries for drug discovery.
  • Medicinal Chemistry: Enables structure-activity relationship (SAR) studies and lead optimization processes in academic and industrial labs.
  • Fine Chemical Synthesis: Employed in multi-step organic syntheses requiring a complex, functionalized heterocyclic core.
  • Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for GMP and non-GMP production of active pharmaceutical ingredients (APIs).

Basic Information

Product Name 3-Isoquinolinecarboxamide, n-[[3-[4-(Diethylamino)-6-Quinazolinyl]Phenyl]Methyl]-n-Methyl-
CAS No. 950568-48-6
Molecular Formula C30H30N6O
Molecular Weight 490.60 g/mol
Synonyms N-[[3-[4-(Diethylamino)-6-quinazolinyl]phenyl]methyl]-N-methyl-3-isoquinolinecarboxamide; 950568-48-6; 3-Isoquinolinecarboxamide, N-[[3-[4-(diethylamino)-6-quinazolinyl]phenyl]methyl]-N-methyl-; N-Methyl-N-({3-[4-(diethylamino)quinazolin-6-yl]phenyl}methyl)isoquinoline-3-carboxamide; Kinase Inhibitor Intermediate; Quinazoline-Isoquinoline Hybrid Compound
EINECS Contact for details

Quality Control

Our production of this advanced intermediate adheres to stringent quality protocols to ensure batch-to-batch consistency and purity suitable for research and development. Each lot is supported by a comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles. We can supply material compliant with ICH guidelines for stability and impurity characterization upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). The material should be kept under an inert atmosphere if long-term storage is required to prevent potential degradation.

Specification

Item Specification
Appearance White to off-white solid
Identification (IR) Conforms to structure
Identification (HPLC) Conforms to reference
Assay (HPLC) ≥ 97.0%
Purity (HPLC) ≥ 98.0%
Water Content (KF) ≤ 0.5%
Residue on Ignition ≤ 0.1%
Heavy Metals ≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.